• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » Families sue Synthes over patients’ deaths | Legal Roundup

Families sue Synthes over patients’ deaths | Legal Roundup

March 2, 2012 By MassDevice staff

Synthes

The families of 2 patients who died on the operating table during spine surgery involving the use of Synthes’ Norian XR bone cement are suing the company and 4 former executives for wrongful death and elder abuse, according to the Philadelphia Inquirer.

The lawsuit, filed in California Superior Court, was brought by the families of Ryoichi Kikuchi and Barbara Marcelino, both 83. They died after surgeons injected the bone cement during their procedures, but there is no definitive link between their deaths and use of the cement as a cause of death, according to the newspaper.

Kikuchi’s and Marcelino’s blood pressure plunged after the injections and doctors could not being them back, according to the Inquirer.

Synthes, which is being acquired by Johnson & Johnson (NYSE:JNJ) for $21.3 billion, paid paid $22.5 million in fines and was forced to sell off the Norian subsidiary to settle federal criminal charges that it ran an off-label promotion scheme for the Norian XR cement. Kensey Nash (NSDQ:KNSY) later paid $22 million for the entire Norian product line, agreeing to manufacture the Norian products for exclusive distribution by Synthes. Kensey Nash is also named in the patients’ families’ lawsuit, according to the Inquirer.

Four Synthes executives – Michael Huggins, Thomas Higgins, John Walsh and Richard Bohner – were sentenced to prison terms after pleading guilty to misdemeanor charges over the scheme.

"The victims’ families are furious and deeply hurt over their recent discovery of the true cause of their loved ones’ deaths," Gregory Rueb, the lawyer representing the families, told the newspaper. "I have never seen such despicable conduct by a corporation so desperate to make profits and maintain a competitive edge at the expense of human lives."

 Bovie Medical settles suits against former Bovie Canada head
Bovie Medical (NYSE:BVX) said it will take a $737,000 writedown and pay $668,000 to the former head of the Bovie Canada arm it formed after acquiring Lican Developments for $350,000 in cash in 2006.

The Melville, N.Y.-based electro-surgery device maker said it will also reimburse Lican founder and president, Steve Livneh, for any unpaid expenses incurred while he was serving as a consultant to Bovie. The deal also calls for Bovie to give Livneh the intellectual property behind its Modular Ergonomic Grip; an exclusive license to sell its Seal-N-Cut device in China; royalties of 3% on sales of the Seal-N-Cut device outside China; and a 1-time payout of 5% of the sale price should it unload the Seal-N-Cut device.

In return Livneh will kick 3% royalties on Chinese sales of the device back to Bovie; a 5% royalty on any sale of the technology covered by the transferred IP; and 3% royalties on sales of devices stemming from that IP, excluding the RF Skin Resurfacing and Tip-On-Tube products.

Aside from the 4th-quarter writedown, Bovie said it also incurred a $194,000 charge for the transfer of inventory and molds to Livneh.

Bovie is also embroiled in a shareholders’ lawsuit alleging that mismanagement and nepotism have caused the company to miss out on commercialization and acquisition opportunities. Read more

 NuVasive slaps former sales execs with breach-of-contract suit
NuVasive (NSDQ:NUVA) sued 2 former sales executives, James Greene and William Vanlandingham, who jumped ship for Rival Lanx Inc. in February, accusing them of violating non-compete agreements.

"On or around October, 2011, Lanx began a raid on NuVasive employees across
the country," according to the lawsuit, filed in the U.S. District Court for Southern Texas. "This raid started in Western New York, where 5 NuVasive salespeople left NuVasive to work for Lanx, and a top consulting surgeon for NuVasive announced that he had become a consultant for Lanx. Two months later, 3 top California directors and managers were recruited from NuVasive to work for Lanx. After learning of Lanx’s raid on its California employees, NuVasive sent Lanx a cease and desist letter. Lanx responded dismissively, and continued to raid NuVasive employees."

"[I]n late 2011 and early 2012, Lanx targeted NuVasive’s Texas workforce, and started recruiting Mr. Greene, Mr. Vanlandingham, and others, to join the company," according to the lawsuit, which seeks legal fees, injunctions barring further contract breaches, damages, punitive damages, and pre- and post-judgment interest.

 Validity trial to go forward in Pitt v Varian case
The University of Pittsburgh followed up its $37 million jury verdict against Varian Medical Systems (NYSE:VAR) with another legal win, after a Pennsylvania judge rules that a trial weighing the patent’s validity will go forward in April. Read more

 FDA nixes Washington Legal Foundation’s petition on 510(k)s

The FDA denies a citizen’s petition from the Washington Legal Foundation demanding that it ignore the recommendations of the Institute of Medicine for reforming the 510(k) protocol. Read more

 Amgen’s $1.16B Micromet buyout can proceed

A Delaware judge shot down a shareholders’ bid to stymie Amgen’s (NSDQ:AMGN) $1.16 billion bid for Micromet (NSDQ:MITI). Read more

 Zecotek Imaging sues Saint-Gobain, Philips over crystal patents
Zecotek Imaging Systems, a subsidiary of Zecotek Photonics (CVE:ZMS) , sues Saint-Gobain (EPA:SGO) and Philips Healthcare (NYSE:PHG), alleging infringement of a patent covering the methods for growing lutetium fine silicate scintillation crystals used in imaging devices. Read more

Filed Under: Food & Drug Administration (FDA), Legal News, News Well Tagged With: Amgen, Bovie Medical Corp., depuysynthes, Legal Roundup, Micromet, Norian Corp., Nuvasive, Philips, Saint-Gobain, Varian Medical Systems, Washington Legal Foundation, Zecotek

In case you missed it

  • Ambu replaces CEO with new leadership
  • Moderna’s first bivalent COVID-19 vaccine booster candidate shows promise
  • AdvaMed joins Biden’s Joint Supply Chain Resilience Working Group
  • FDA clears Accelus’ Toro-L interbody fusion system
  • Teleflex’s UroLift cleared in China to treat BPH
  • Globus Medical announces first surgeries with Excelsius3D
  • Abbott reports positive data on heart valve therapies
  • OncoRes Medical raises another $12.5M
  • NeuroMetrix’s Quell neuromodulation device wins FDA de novo nod to treat fibromyalgia
  • Inogen appoints Agnes Lee as senior VP of investor relations, strategic planning
  • Google Health hires FDA’s chief digital health officer
  • ApiJect picks up $111M investment from Royalty Pharma, Jefferies
  • Expect more heart and lung failure years after COVID, Abbott’s heart failure CMO says
  • Teleflex wins Health Canada nod for Manta vascular closure device
  • Study shows strong performance, improved outcomes with Medtronic Evolut TAVR
  • New FDA clearance expands indications for Xact Robotics’ ablation system
  • Medtronic’s Resolute Onyx drug-eluting stent demonstrates strong safety, efficacy

RSS From Medical Design & Outsourcing

  • BD, Mitsubishi Gas Chemical partner on better materials for plastic syringes
    BD (NYSE:BDX) announced that it partnered with Mitsubishi Gas Chemical Company on applying new technology to pre-fillable syringes. MGC develops the Oxycapt technology designed to integrate the best of plastic and glass for plastic syringes. BD and Tokyo-based MGC will work together to apply Oxycapt technology to the next generation of pre-fillable syringes (PFS) for advanced… […]
  • Ambu replaces CEO with new leadership
    Ambu today said it has hired board member Britt Meelby Jensen to replace CEO Juan Jose Gonzalez, effective tomorrow. “Since Juan Jose Gonzalez joined as CEO in 2019, Ambu has made good progress and achieved important milestones on the strategic transformation into the world’s largest single-use endoscopy company,” Ambu Chair Jørgen Jensen said in a… […]
  • AdvaMed joins Biden’s Joint Supply Chain Resilience Working Group
    AdvaMed executive Abby Pratt has joined the executive committee for the Biden administration’s Joint Supply Chain Resilience Working Group, the medtech industry association said today. The working group’s members from government and industry will assist with implementation of the National Strategy for a Resilient Public Health Supply Chain. Pratt oversees supply chain issues as SVP… […]
  • Toray develops new stretchable film for medical devices
    Toray Industries has a new stretchable film based on its proprietary polymer Reactis technology, with potential applications that include robotics and biological and industrial sensors. Tokyo-based Toray said it shipped samples to customers and plans research and development efforts to commercialize the new grade of film. “Recent years have increased the potential for developing stretchable… […]
  • Google Health hires FDA’s chief digital health officer
    Former FDA Chief Digital Health Officer of Global Strategy and Innovation Bakul Patel has started a new job with Google after 13 years with the regulatory agency. Patel became senior director, global digital health strategy and regulatory for Google Health earlier this month, he said on LinkedIn. Patel recounted highlights of his “incredible journey since… […]
  • Expect more heart and lung failure years after COVID, Abbott’s heart failure CMO says
    Two years into the COVID-19 pandemic, we know more than ever about the SARS-CoV-2 virus and how quickly it moves to ravage the human body. What remains to be seen is how the virus — and perhaps more importantly, our immune system’s response to it — will affect the health of people long after infection,… […]
  • FDA moves forward with Voluntary Improvement Program to bolster medical device quality
    Kathryn Burke, Emergo Group The U.S. Food and Drug Administration has issued new draft guidance to establish a full-blown voluntary program for improving quality-related processes in medical device manufacturing following promising results of a pilot program. The FDA guidance stems from a pilot undertaken by the agency along with the Medical Device Innovation Consortium (MDIC) in 2018.… […]
  • How Minnetronix Medical helped Lazurite with its wireless surgical camera
    Minnetronix Medical (St. Paul, Minnesota) has played an important development and manufacturing partner role with Lazurite’s wireless surgical camera system. It’s been nearly two months since Lazurite (formerly Indago) announced FDA 510(k) clearance of its ArthroFree system. ArthroFree combines proprietary low-heat, high-intensity Meridiem light engine technology with advanced camera, battery and wireless transmission technologies and… […]
  • Instron releases TrendTracker data analysis workflow platform
    Instron announced that it released the TrendTracker module in Bluehill Central for accelerating data analysis workflows. Norwood, Massachusetts-based Instron designed TrendTracker with an intuitive interface to improve the data analysis workflow of single or multi-location materials testing laboratories. According to a news release, the platform features quick searching and the ability to display and analyze… […]
  • Henry Schein hires former Medline veteran to drive ‘One Distribution’ push
    Henry Schein (Nasdaq:HSIC) today named Dirk Benson as VP and chief commercial officer of the medical device manufacturer and distributor’s North America Distribution Group (NADG). Melville, New York-based Henry Schein is the world’s largest provider of health care supplies and services for office-based dental and medical practitioners, and NADG is the company’s largest business group. The… […]
  • The road to a robot: Medtronic’s development process for its Hugo RAS system
    Elephants are the perfect analogy for surgical robotics, Medtronic (NYSE:MDT) VP of Marketing for Surgical Robotics Mike Stow says. Speaking on the “Road to a robot: Designing technology to address unmet needs & barriers” panel at DeviceTalks Boston last week, Stow explained that elephants are big, taking up a lot of space and that they eat a lot, making… […]

Leave a Reply

You must be logged in to post a comment.

Primary Sidebar

DeviceTalks Weekly

May 13, 2022
Our Pre-Post-DeviceTalks Boston episode, also MedtronicTalks replay with Gastro CMO Austin Chiang
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS